Edition:
United Kingdom

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

5.75USD
20 Apr 2018
Change (% chg)

$0.05 (+0.88%)
Prev Close
$5.70
Open
$5.70
Day's High
$5.75
Day's Low
$5.70
Volume
21,153
Avg. Vol
23,394
52-wk High
$6.05
52-wk Low
$2.30

Latest Key Developments (Source: Significant Developments)

Harvard Bioscience Says Co Entered Into A Financing Agreement
Friday, 2 Feb 2018 

Feb 2 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE INC - ON JAN 31, 2018, CO ENTERED INTO A FINANCING AGREEMENT - SEC FILING.HARVARD BIOSCIENCE INC - FINANCING AGREEMENT PROVIDES SENIOR SECURED CREDIT FACILITIES HAVING $64 MILLION TERM LOAN, $25 MILLION REVOLVING CREDIT LINE.  Full Article

Harvard Bioscience reports Q3 loss $0.01/shr
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Harvard Bioscience Inc :Harvard Bioscience reports third quarter 2017 financial results.Sees Q4 2017 non-GAAP earnings per share $0.05 to $0.06.Sees Q4 2017 GAAP loss per share about $0.00 to $0.01.Q3 revenue $25.1 million versus i/b/e/s view $24.6 million.Q3 non-GAAP earnings per share $0.03.Q3 GAAP loss per share $0.01.Q3 earnings per share view $0.03 -- Thomson Reuters I/B/E/S.Harvard Bioscience Inc - ‍reaffirming its Q4 revenue guidance​.  Full Article

Harvard Bioscience Q2 adjusted earnings $0.03/shr
Thursday, 28 Jul 2016 

Harvard Bioscience Inc : Harvard Bioscience Reports Second Quarter 2016 Financial Results . Updating Full-Year Financial Guidance To Reflect Current Foreign Currency Exchange Rates, Including Impact Of Brexit Uncertainty . Q2 Shr View $0.03, Rev View $26.6 Mln -- Thomson Reuters I/B/E/S . Sees Full-Year 2016 Non-Gaap Diluted Earnings Per Share Of $0.16 To $0.18 . Fy2016 Shr View $0.18, Rev View $109.7 Mln -- Thomson Reuters I/B/E/S . Q2 Gaap Shr Loss $0.02 . Sees Fy 2016 Gaap Shr About $0.00 To $0.02 . Q2 Revenue Fell 9 Pct To $26.1 Mln .Q2 Non-Gaap Shr $0.03.  Full Article

Harvard Bioscience posts Q1 loss of $0.02/share
Thursday, 12 May 2016 

Harvard Bioscience Inc : Harvard Bioscience reports first quarter 2016 financial results . Q1 non-GAAP earnings per share $0.05 . Q1 revenue rose 4.7 percent to $27 million . Q1 GAAP loss per share $0.02 . Reaffirming its financial guidance for full year 2016 .Sees FY 2016 non-GAAP earnings per share $0.17 to $0.19.  Full Article

Harvard Bioscience files for non-timely 10-Q
Tuesday, 10 May 2016 

Harvard Bioscience Inc :Files for non-timely 10-Q - SEC filing.  Full Article